CRSOX
Price
$29.81
Change
+$0.37 (+1.26%)
Updated
Jul 22 closing price
Net Assets
1.42B
PCRPX
Price
$16.57
Change
+$0.18 (+1.10%)
Updated
Jul 22 closing price
Net Assets
4.08B
Interact to see
Advertisement

CRSOX vs PCRPX

CRSOX vs PCRPX Comparison Chart in %
View a ticker or compare two or three
VS
CRSOX vs. PCRPX commentary
Jul 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSOX is a Hold and PCRPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PCRPX has more cash in the bank: 4.08B vs. CRSOX (1.42B). PCRPX pays higher dividends than CRSOX: PCRPX (12.57) vs CRSOX (7.02). CRSOX was incepted earlier than PCRPX: CRSOX (22 years) vs PCRPX (18 years). PCRPX (1.08) is less costly to investors than CRSOX (0.85). PCRPX is a more actively managed with annual turnover of: 268.00 vs. CRSOX (60.00). CRSOX has a lower initial minimum investment than PCRPX: CRSOX (250000) vs PCRPX (1000000). CRSOX annual gain was more profitable for investors over the last year : 30.66 vs. PCRPX (27.73). CRSOX return over 5 years is better than : 66.52 vs. PCRPX (56.62).
CRSOXPCRPXCRSOX / PCRPX
Total Expense Ratio0.801.0080%
Annual Report Gross Expense Ratio0.851.0879%
Fund Existence22 years18 years-
Gain YTD22.74521.670105%
Front LoadN/AN/A-
Min. Initial Investment250000100000025%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B4.08B35%
Annual Yield % from dividends7.0212.5756%
Returns for 1 year30.6627.73111%
Returns for 3 years42.1242.13100%
Returns for 5 years66.5256.62117%
Returns for 10 years101.48105.6396%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JUNT37.860.28
+0.76%
AllianzIM US Equity Buffer10 Jun ETF
FLOT50.99N/A
N/A
iShares Floating Rate Bond ETF
TDOG14.91N/A
N/A
21Shares Dogecoin ETF
HYGH86.54-0.05
-0.06%
iShares Interest Rate Hdg Hi Yld Bd ETF
EEV11.47-0.69
-5.67%
ProShares UltraShort MSCI Emerging Mkts